Botanical species · safety record

Brunfelsia uniflora

The EFSA Compendium of Botanicals holds 4 constituent measurements for Brunfelsia uniflora. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Brunfelsia uniflora (Pohl) D.Don

4Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Also recorded as

Brunfelsia hopeana (Hook.) Benth.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Scopoletin	Roots and other underground parts	Solvent extraction	0.011 Percent	—	Resolve DOI
Coumarins	Roots and other underground parts	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Scopoletin	Seed	Solvent extraction	5e-04 Percent	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Steroidal glycosides	Roots and other underground parts	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

de Campos, Sonia Machado. Scopoletin in Brunfelsia seeds. Anais. Acad. Brasil Cienc., 1964, p. 511-513.
Oliveira, EJ., Romero, MA., Silva, MS., Silva, BA., Medeiros, IA. Intracellular calcium mobilization as a target for the spasmolytic action of scopoletin. PLANTA MEDICA, 2001, vol. 67, no. 7, p. 605-608. DOI
Ichiki, Hiroyuki., Yahara, Shoji., Nohara, Toshihiro., Nakasumi, Tetsuo., Irino, Nobuto., Takaoka, Tsuneo. Studies on the constituents of Brunfelsia hopeana Benth. Natural Medicines, 1994, vol. 48, no. 4, p. 314-316.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature